Reviewed by Dietitian Kelly Plowe, M.S., RD Key Points GLP-1s curb appetite and slow digestion, supporting weight loss but complicating nutrient needs
Managing conflicts of interest in the development of health guidelines
The stomach essentially stops functioning normally
Scientific research Preclinical and early clinical studies of BPC-157 confirm acceleration of musculoskeletal injury healing (muscles, tendons, ligaments, bones), protection of GI mucosa from damage (NSAIDs, stress, ulcerative diseases), anti-inflammatory action in chronic conditions (arthritis, inflammatory bowel diseases), angiogenesis stimulation (new vessel formation via VEGF/NO pathways), liver and cardiovascular protection from oxidative stress, and accelerated post-surgical recovery
Immuno-Grade GLP1 Receptor Antibodies GLP1 (IHC-grade), Glucagon-Like Peptide 1